MODULASI SEL PUNCA MESENKIMAL DALAM MENURUNKAN KADAR HIGH SENSITIVITY C-REACTIVE PROTEIN SEBAGAI TERAPI NEFRITIS LUPUS

Indah Putri Maharani, Zainal Arifin Adnan, Arief Nurudhin

DOI: https://doi.org/10.23917/biomedika.v9i1.4340

Abstract

Systemic Lupus Erythematosus merupakan penyakit inflamasi autoimun kronis dengan gambaran klinis luas dan perjalanan penyakit beragam. Pemberian pristan intraperitoneal dapat menginduksi lupus pada mencit. Secretome sel punca mesenkimal bekerja secara parakrin memberikan efek antinflamasi dan imunomodulasi antara lain mensupresi sel T dan sel B autoreaktif. High Sensitivity C-Reactive Protein (hsCRP) terkait dengan patogenesis SLE dan selaras dengan aktifitas penyakit.Tujuan Penelitian adalah untuk mengetahui pengaruh secretome sel punca mesenkimal terhadap kadar hsCRP pada mencit model lupus dengan induksi pristan. Desain penelitian adalah eksperimental dengan randomisasi, post test only control group design, sampel 21 ekor mencit betina Mus Musculus galur Balb/C, dibagi 3 kelompok yaitu kelompok kontrol (injeksi intraperitoneal NaCl 0,9% 0,5 ml), kelompok perlakuan (injeksi pristan intraperitoneal 0,5 ml) dan kelompok terapi (injeksi intraperitoneal pristan 0,5 ml dan secretome 0,45 ml). Penelitian dilakukan selama 3 minggu, secretome diberikan pada akhir penelitian. Sesudah perlakuan dinilai kadar hsCRP secara ELISA. Analisis statistik menggunakan SPSS 22 for windows dengan uji Kruskal-Wallis dilanjutkan Mann-Whitney U test. P bermakna jika p<0,05. Hasil penelitian menunjukkan bahwa rata-rata kadar hsCRP pada ketiga kelompok yaitu kontrol 440.68(110.08-564.29) ng/ mL; perlakuan (pristan) 2964.26(601.13-3926.10) ng/mL; terapi pristan+secretome) 506.93(207.62-1473.46) ng/mL, dengan kemaknaan p=0.008. Terdapat perbedaan bermakna kadar hsCRP antara kelompok pristan vs pristan+secretome (2457.33 ng/mL; p=0.047). Secretome sel punca mesenkimal mampu menurunkan kadar hsCRP pada mencit model lupus dengan induksi pristan.

Kata Kunci: High Sensitivity C-Reactive Protein, Nefritis lupus, Secretome

Full Text:

PDF

References

Carrion, F.A., Figueroa, F.E. 2011. Mesenchymal Stem Cells for the Treatment of Systemic LupusErythematosus: Is the Cure for Connective Tissue Disease Within Connective Tissue?. Stem Cell Research & Therapy, vol. 2, no. 23, hlm. 1-8.

Chun, H.Y., Chung, J.W., Kim, H.A., Yun, J.M., Jeon, J.Y., Ye, Y.M., Kim, S.H., Park, H.S., Suh, C.H. 2007. Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus. Journal of Clinical Immunology, vol. 2007, no. 27, hlm. 461–466.

Drago, D., Cossetti, C., Iraci, N., Gaude, E., Musco, G., Bachi, A., Pluchino, S. 2013. The Stem Cell Secretome and It’s Role in Brain Repair. Biochimie, vol. 2013, no. 95, hlm. 2271-2285.

Firooz, N., Albert, D.A., Ishimori, M., Berel, D., Weisman, M.H. 2011. High Sensitivity C Reactive Protein and Erythrocyte Sedimentation Rate in Systemic Lupus Erythematosus. Lupus, vol. 2011, no. 20, hlm. 588-597.

Gnecchi, M., He, H., Liang, O.D., Mello, L.G., Morello, F., Mu, H., Noiseux, N., Zhang, L. Pratt R.E, Ingwall, J.S., Dzau, V.J. 2005. Paracrine Actions Accounts for Marked Protection of Ischemic Heart by Akt-Modified Mesenchymal Stem Cells. Nature Publishing Group, vol. 11, hlm. 367-368.

Kuroiwa, T., Iwasaki, T., Sano, H. 2006. Hepatocyte Growth Factor Prevents Lupus Nephritis in Murine Lupus Model of Chronic Graft-Versus_Host Disease. Arthritis Research and Therapy, vol. 8, no. 4, hlm. 1-8.

Kyurkchiev, D., Bochev, I., Todorova, E.I., Mourdjeva, M., Oreshkova, T., Belemezova, K., Kyurkchiev, S. Secretion of Immunoregulatory Cytokines by Mesenchymal Stem Cells. World Journal of Stem Cells, vol. 2014, no. 26, hlm. 552-562.

Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J., Larson, B.L., Prieto, L.S., Delafontaine, P., Prockop, D.J. 2009. Intravenous hMSCs Improve Myocardial Infarction in Mice Because Cells Embolized in Lung Are Activated to Secrete the Anti-Inflammatory Protein TSG-6. Cell Stem Cell, vol. 5, no. 1, hlm. 54 – 63.

Liang, J., Zhang, H., Hua, B., Wang, H., Lu, L., Shi, S., Hou, Y., Zeng, X., Gilkeson, G.S., Sun, L. 2010. Allogenic Mesenchymal Stem Cell Transplantation in Refractory Systemic Lupus Erythematosus : A Pilot Clinical Study. Annals of the Rheumatic Disease, vol. 2010, no. 69, hlm. 1423-1429.

Madrigal, M., Rao, K.S., Riordan, N.H. 2014. A Review of Therapeutic Effects of Mesenchymal Stem Cell Secretions and Induction of Secretory Modification by Different Culture Methods. Journal of Translational Medicine, vol. 12, no. 260, hlm. 1-14.

Meirelles, L.D.S., Fontes, A.M., Covas, D.T., Caplan, A.I. 2009. Mechanism Involved in the Therapeutic Properties of Mesenchymal Stem Cells. Cytokine Growth Factor Review, vol. 2009, no. 20, hlm. 419-427.

Mok, C.C., Birmingham, D.J., Ho, L.Y., Hebert, L.A., Rovin, B.H. 2013. High Sensitivity C-Reactive Protein, Disease Activity and Cardiovascular Risk Factors in Systemic Lupus erythematosus. Arthritis Care & Research, vol. 65, no. 3, hlm. 441-447.

Mok, C.C. dan Lau, C.S. 2003. Pathogenesis of Systemic Lupus Erythematosus. Journal of Clinical Pathology, vol. 2003, no. 56, hlm. 481-490.

Musai, M. 2010. Terapi Lupus Eritematosus Sistemik dengan Penghambatan Kostimulasi Sel T. Majalah Kedokteran Indonesia, vol. 60, no. 10, hlm. 1-6.

Okunishi, K., Dohi, M., Fujio, K., Nakagome, K., Tabata, Y., Okasora, T., Seki, M., Shibuya, M., Imamura, M., Harada, H., Tanaka, R., Yamamoto, K. 2007. Hepatocyte Growth Factor Significantly Suppresses Collagen-Induced Arthritis in Mice. The Journal of Immunology, vol. 2007, no. 179, hlm. 5504-5513.

Perhimpunan Reumatologi Indonesia. 2011. Rekomendasi Perhimpunan Reumatologi Indonesia Untuk Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Perhimpunan Reumatologi Indonesia.

Perry, D., Sang, A., Yin, Y., Zheng, Y.Y., Morel, L. 2010. Murine Models of Systemic Lupus Erythematosus. Journal of Biomedicine and Biotechnology, vol. 2011, hlm. 1-20.

Postal, M., Costallat, L.T. dan Appenzeller, S. 2012. Biological Therapy in Systemic Lupus Erythematosus. International Journal of Rheumatology, vol. 2012, hlm.1-9.

Rezaieyazdi, Z., Sahebari, M., Hatef, M.R., Abbasi, B., Rafatpanah, H., Afshari, J.T., Esmaily, H. 2011. Is There Any Corelation Between High Sebsitive CRP and Disease Activity in Systemic Lupus Erythematosus?. Lupus, vo. 2011, no. 20, hlm. 1494-1500.

Reeves, W.H., Lee, P.Y., Weinstein, J.S., Satoh, M., Lu, L. 2009. Induction of Autoimmunity by Pristane and Other Naturally Occurring Hydrocarbons. Trends in Immunology, vol. 30, no. 9, hlm. 455–464.

Song, M., Heo, J., Chun, J.Y., Bae, H.S., Kang, J.W., Kang, H. 2014. The Paracrine Effects of Mesenchymal Stem Cells Stimulate the Regeneration Capacity of Endogenous Stem Cells in the Repair of a Bladder Outlet Obstruction Induced Overactive Bladder. Stem Cells Reviews, vol. 23, no. 6, hlm. 654 – 663.

Suarjana, I.N. 2014. Imunopatogenesis Lupus Eritematosus Sistemik, hlm. 3331-3345. dalam : Simadibrata M., Syam A.F., Setiati S., Setyohadi B., Alwi I (edt). Buku Ajar Ilmu Penyakit Dalam Jilid III. Edisi VI. Interna Publishing FK UI, Jakarta.

Sun, L., Wang, D., Liang, J., Zhang, H., Feng, X., Wang, H. 2010. Umbilical Cord Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemis Lupus Erythematosus. Arthritis & Rheumatism, vol. 62, no. 8, hlm. 2467-2475.

Yang, C.C., Shih, Y.H., Ko, M.H., Hsu, S.Y., Cheng, H., Fu, Y.S. 2008. Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly After Complete Transection of the Rat Spinal Cord. PloS one, vol. 3, issue 10, hlm. 1-11.

Yap, D.Y.H. dan Lai, K.N. 2010. Cytokines and Their Roles in Pathogenesis of Systemic Lupus Erythematosus: From Basics to Recent Advances. Journal of Biomedicine and Biotechnology, vol. 2010, hlm. 1-10.

Article Level Metrics

Refbacks

  • There are currently no refbacks.